-- 
Takeda Rating Cut to Aa3 by Moody’s on Nycomed Acquisition

-- B y   G e a r o i d   R e i d y
-- 
2011-10-03T05:21:45Z

-- http://www.bloomberg.com/news/2011-10-03/takeda-rating-cut-to-aa3-by-moody-s-on-nycomed-acquisition.html
Takeda Pharmaceutical Co. had its
issuer rating cut two notches to Aa3 from Aa1 by Moody’s
Investors Service on concern the acquisition of Nycomed will
worsen the Japanese drugmaker’s balance sheet. The outlook for
the rating is stable, Moody’s said today in a statement.  To contact the editor responsible for this story:
Gearoid Reidy at 
 greidy1@bloomberg.net  